跳至主要内容
临床试验/CTRI/2015/02/005575
CTRI/2015/02/005575已完成未知

Comparative study of tolerability and efficacy of haloperidol versus olanzapine in schizophrenia

Government Medical College and Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosis of paranoid schizophrenia according to ICD-10
  • Attending the outpatient clinic or those admitted to the inpatient services
  • Patients in the age group of 18 to 65 years Patients having normal intelligence
  • Patients who were willing to give written informed consent were included.
  • Patients should have been drug naïve for at least 2 weeks prior to the baseline assessments.

排除标准

  • Patients with past history of poor response or hypersensitivity to olanzapine or haloperidol were excluded.
  • We also excluded patients with co-morbid substance related disorders except nicotine and caffeine
  • Patients with chronic medical illness, neurological disorders, head injury, tumors, movement disorder, pregnant and lactating females.
  • Any other condition which affected the quality of life of the patients was an exclusion criterion.
  • Patients who were unwilling to participate in the study were also excluded.

研究者

发起方
Government Medical College and Hospital

相似试验

Comparative study of tolerability and efficacy of... | 临床试验